ACTINIUM PHARMACEUTICALS, INC. Preferred Stock, Par or Stated Value Per Share
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2026-08-07
- 2026-06-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2026-03-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2025-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Par or Stated Value Per Share as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-25 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $0.00 10-K · filed 2020-05-08 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 | |
| 2014-09-30 | $0.01 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $0.01 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $0.01 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $0.01 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $0.00 10-K · filed 2014-02-28 | $0.01 10-K · filed 2013-03-29 |
| 2012-09-30 | $0.01 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $0.01 10-Q/A · filed 2012-08-29 | |
| 2012-03-31 | $0.01 10-Q · filed 2012-04-23 | |
| 2011-12-31 | $0.01 10-K · filed 2013-03-29 | |
| 2011-09-30 | $0.01 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $0.01 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $0.01 10-K · filed 2012-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |